Anavex Life Sciences Corp (AVXL)

[blu_1]

"disappointing mmse Ph 2 scores"? Umm, hardly. Stabilised MMSE out 31 weeks is not too shabby. And, improving MMSE for the 7 on 273 alone at 31 weeks. For some reason, gee I wonder (sarcasm), Anavex is being held to a different standard by the digital rags. Simply slowing the progression, the goal of every Alzheimers drug in development, isn't enough. No, only cure or indefinite stabilzation is acceptable. Keep in mind Anavex's patient pool is sicker and further progressed than the other studies and the Anavex study doesn't have patients taking the max tolerated dose of the drug. Donepezil is suppressing 273 by taking up space on receptors too. And of course the author complains about lack of control group, not understanding this is an adaptive study design encouraged by fda and efficacy of this trial is only a secondary end point. Oracle, Motley Fool, and The Street employ hacks that don't do their DD and listen too much to the FUD put out by hedge funds and the likes of Adam Feuerstein. In fact, it would not surprise me if they are working for the hedge funds themselves